|Trial status||Trial open for recruitment|
Interventional with experimental drug
|Phase||Trial phase 1|
|Inclusion criteria||Relasped/refractory patient|
The new Institut Jules Bordet, a building for the practice of medical excellence now and in the future. Meeting at the end of November 2021 on the ULB campus in Anderlecht.